Author:
Youssef Jihan A.,Badr Mostafa Z.
Reference734 articles.
1. Abbott BD (2009) Review of the expression of peroxisome proliferator-activated-receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development. Reprod Toxicol 27:246–257
2. Aberle J, Hopfer I, Beil FU, Seedorf U (2006) Association of the T+294C polymorphism in PPAR delta with low HDL cholesterol and coronary heart disease risk in women. Int J Med 13:108–111
3. Adrian TE, Hennig R, Friess H, Ding X (2008) The role of PPAR gamma receptors and leukotriene B(4) receptors in mediating the effects of LY293111 in pancreatic cancer. PPAR Res 2008:827096
4. Afzelius BA (1965) The occurrence and structure of microbodies: a comparative study. J Cell Biol 26:835–843
5. Agrawal R, Jain P, Dikshit SN (2012) Balaglitazone: a second generation peroxisome proliferator-activated receptor (PPAR) gamma(γ) agonist. Mini Rev Med Chem 12:87–97